Camilleri J P, Fabiani J N
Biomedicine. 1977 Dec;26(6):353-6.
It has been shown that localized myocardial ischemia is accompanied by microvascular changes which produce capillary obstruction when blood flow is restored. This so-called no-reflow phenomenon has been noted in the brain, kidney, dermis and, more recently, in the myocardium. Ultrastructural studies have pointed out the role of myocardial and endothelial cells swelling. It seems likely that such damage of the vascular bed may constitute the first irreversible change during ischemia and result in failure to obtain successful reperfusion of involved myocardium. It can be suggested on the basis of recent clinical and experimental observations, that this phenomenon may play a role in subendocardial necrosis associated with cardiac surgery, and in myocytolytic necrosis. In both of these conditions, the most salient features are the microcirculatory defect and the reperfusion injury following transient ischemia. Further investigations are needed to determine the basic alterations induced by no-reflow phenomenon and the value of various prophylactic and therapeutic measures.
研究表明,局部心肌缺血伴有微血管变化,当血流恢复时会导致毛细血管阻塞。这种所谓的无再流现象已在脑、肾、真皮中被观察到,最近在心肌中也有发现。超微结构研究指出了心肌细胞和内皮细胞肿胀的作用。血管床的这种损伤似乎可能是缺血期间的首个不可逆变化,并导致受累心肌无法成功再灌注。根据最近的临床和实验观察结果,可以推测这种现象可能在与心脏手术相关的心内膜下坏死以及肌溶解坏死中起作用。在这两种情况下,最显著的特征是微循环缺陷和短暂缺血后的再灌注损伤。需要进一步研究以确定无再流现象引起的基本改变以及各种预防和治疗措施的价值。